The nationwide New Horizons Research Campaign funds promising new cystic fibrosis (CF) research projects in academic and hospital institutions. Supporting research of the highest scientific quality, the NH program also endeavors to fund those applications with the greatest relevance to finding improved treatments or a cure for CF.
Principal Investigators (PIs) must work in their labs to be eligible for funding.
- New Horizons provides a minimum of two $70,000 awards per year for two years via two annual contracts. These awards are based on CFRI’s Research Advisory Committee (RAC) reviewed and designated ‘satisfactory’ progress reports, financial reports, and relevant fund availability to the research project goals.
- Announcement for Letters of Intent (LOI) is made in September with the LOI due to CFRI the first Monday of the second week in November from principal investigators for two-year research projects up to $70,000 per year that are highly relevant to CF and are original, probing and/or pioneering a new approach to a therapy or cure.
- Priority is given to proposals of superior scientific quality. This funding opportunity is open to research institutions within the United States. The NH awards also provide seed funding for promising new lines of basic and clinical CF research that show prospects of future funding by other sources, such as the National Institutes of Health (NIH).